In melanoma, gastric, lung, liver and prostate cancers, tumor-infiltrating B cells can persistently express VEGF (vascular endothelial growth factor) and other pro-angiogenic genes via STAT3 signaling, fostering tumor progression by increasing angiogenesis (Yang et al., 2013). The gene discussed is VEGFA; the disease is prostate carcinoma.